Тромбоксан (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Тромбоксан" in Ukrainian language version.

refsWebsite
Global rank Ukrainian rank
4th place
5th place
2nd place
4th place
6th place
6th place
1st place
1st place
low place
6,865th place

americanheart.org

  • [1] American Heart Association: Aspirin in Heart Attack and Stroke Prevention «The American Heart Association recommends aspirin use for patients who've had a myocardial infarction (heart attack), unstable angina, ischemic stroke (caused by blood clot) or transient ischemic attacks (TIAs or „little strokes“), if not contraindicated. This recommendation is based on sound evidence from clinical trials showing that aspirin helps prevent the recurrence of such events as heart attack, hospitalization for recurrent angina, second strokes, etc. (secondary prevention). Studies show aspirin also helps prevent these events from occurring in people at high risk (primary prevention).»

archive.org

doi.org

  • Ito Y (2003). Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice. Eur Surg Res. 35 (5): 408—16. doi:10.1159/000072174. PMID 12928598.
  • Katagiri H (2004). Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology. 39 (1): 139—150. doi:10.1002/hep.20000. PMID 14752832.
  • Yokoyama Y (2005). Role of thromboxane in producing hepatic injury during a hepatic stress disorder. Arch. Surg. 140 (8): 801—7. doi:10.1001/archsurg.140.8.801. PMID 16103291.
  • Cavar I (2011). Anti-thromboxane B2 antibodies protect against acetaminophen-induced liver injury in mice. Journal of Xenobiotics. 1 (1): 38—44. doi:10.4081/xeno.2011.e8.
  • Tohgi, H; S Konno; K Tamura; B Kimura; K Kawano (1992). Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 23 (10): 1400—1403. doi:10.1161/01.STR.23.10.1400. PMID 1412574.
  • Coxib and traditional NSAID Trialists' (CNT) Collaboration (30 травня 2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 382 (9894): 769—79. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
  • Ratti, S; Quarato, P; Casagrande, C; Fumagalli, R; Corsini, A (1998). Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes. European Journal of Pharmacology. 355 (1): 77—83. doi:10.1016/S0014-2999(98)00467-1. PMID 9754941.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Ito Y (2003). Effects of selective cyclooxygenase inhibitors on ischemia/reperfusion-induced hepatic microcirculatory dysfunction in mice. Eur Surg Res. 35 (5): 408—16. doi:10.1159/000072174. PMID 12928598.
  • Katagiri H (2004). Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology. 39 (1): 139—150. doi:10.1002/hep.20000. PMID 14752832.
  • Yokoyama Y (2005). Role of thromboxane in producing hepatic injury during a hepatic stress disorder. Arch. Surg. 140 (8): 801—7. doi:10.1001/archsurg.140.8.801. PMID 16103291.
  • Cavar I (2010). The role of prostaglandin E2 in acute acetaminophen hepatotoxicity in mice. Histol Histopathol. 25 (7): 819—830. PMID 20503171.
  • Tohgi, H; S Konno; K Tamura; B Kimura; K Kawano (1992). Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. Stroke. 23 (10): 1400—1403. doi:10.1161/01.STR.23.10.1400. PMID 1412574.
  • Dockens, RC; Santone, KS; Mitroka, JG; Morrison, RA; Jemal, M; Greene, DS; Barbhaiya, RH (Aug 2000). Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans. Drug Metabolism and Disposition. 28 (8): 973—80. PMID 10901709.
  • Coxib and traditional NSAID Trialists' (CNT) Collaboration (30 травня 2013). Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 382 (9894): 769—79. doi:10.1016/S0140-6736(13)60900-9. PMC 3778977. PMID 23726390.
  • Ratti, S; Quarato, P; Casagrande, C; Fumagalli, R; Corsini, A (1998). Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes. European Journal of Pharmacology. 355 (1): 77—83. doi:10.1016/S0014-2999(98)00467-1. PMID 9754941.

pubmedcentral.nih.gov

ncbi.nlm.nih.gov

web.archive.org